In deliveryUnited KingdomGoods£70,828,856Add to pipeline

Biologic and Biosimilar Medicines

Awarded to Abbvie Ltd, Accord-UK Ltd, Amgen Ltd +16 more

Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)(buyer)

Published: Published 17 September 2024
Deadline: Closed 18 October 2024

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

eTenderwales procured biologic and biosimilar medicines with an estimated value of 70.8 million GBP. The contract was awarded on 22 April 2025 for 96.6 million GBP to 18 pharmaceutical suppliers including Abbvie, Amgen, Biogen, Eli Lilly, Janssen-Cilag, Pfizer, Roche, and others.

Contracting authority

Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
Buyer
Newport, United Kingdom
Authority website ↗
eTenderwales
Buyer
Newport, United Kingdom
Authority website ↗

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Reveal decision makers

Lots (2)

Homecare Multi Supplier
Biosimilars and Biologics
£62,828,856Won by Abbvie LtdWon by Gedeon Richter (UK) LImitedWon by Janssen-Cilag LtdWon by Organon Pharmaceuticals UK LtdWon by Pfizer LtdWon by Roche Products LtdWon by Sandoz LtdWon by Sun Pharma UK LtdWon by Thornton & Ross LtdWon by Teva UK LtdWon by Zentiva Pharma UK LimitedWon by Accord-UK LtdWon by Amgen LtdWon by Biogen Idec LimitedWon by Biosimilar Collaborations Ireland LimitedWon by Celltrion Healthcare United Kingdom LimitedWon by Dr Reddy'sWon by Eli Lilly and Company LimitedWon by Fresenius Kabi Ltd
Rituximab
Procurement for the provision of Rituximab.
£8,000,000

Key details

Country: United Kingdom
Status: In delivery
Category: Goods
Estimated value: £70,828,856
Procedure: Open
Published: 17 September 2024
Deadline: Closed

Classification (CPV)

Pharmaceutical products

Award outcome

Awarded value: £96,642,400
Award date: 22 April 2025
Contract period: 30 June 2025 → 30 June 2028

Winners

Abbvie Ltd
Accord-UK Ltd
Amgen Ltd
Biogen Idec Limited
Biosimilar Collaborations Ireland Limited
Celltrion Healthcare United Kingdom Limited
Dr Reddy's
Eli Lilly and Company Limited
Fresenius Kabi Ltd
Gedeon Richter (UK) LImited
Janssen-Cilag Ltd
Organon Pharmaceuticals UK Ltd
Pfizer Ltd
Roche Products Ltd
Sandoz Ltd
Sun Pharma UK Ltd
Teva UK Ltd
Thornton & Ross Ltd
Zentiva Pharma UK Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

Contract
21 May 2025
Contract Notice
17 September 2024

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

Start for Free See more tenders

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.

See more tenders